Multicenter trial examining the efficacy of a miniaturized and fully self-contained leadless pacemaker percutaneously implanted into the right ventricle. The leadless pacemaker met prespecified pacing and sensing requirements with 1 in 15 patients experiencing adverse device related events.
You are here:
Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker
Submitted by: Tom C. Nguyen
Source: New England Journal of Medicine
Keywords:
Author(s): Vivek Y. Reddy, Derek V. Exner, Daniel J. Cantillon, Rahul Doshi, T. Jared Bunch, Gery F. Tomassoni, Paul A. Friedman, N.A. Mark Estes, III, John Ip, Imran Niazi, Kenneth Plunkitt, Rajesh Banker, James Porterfield, James E. Ip, and Srinivas R. Dukkipati for the LEADLESS II Study Investigators
